Senator: We don't have to choose between industry vitality and safety; Boston Sci to shed 150 temp jobs in Ireland;

 @FierceMedDev: Firewall Created to safeguard against medical-device hacking | Imperial Valley News. News | Follow @FierceMedDev

> Much ado has been made about improving the device approval process while ensuring patient safety. Sen. Al Franken (D-MN) doesn't think these ideas are mutually exclusive and hopes he can help the two sides come together. "I want to be a bridge there," he said. Story

> Boston Scientific ($BSX) says 150 temporary jobs are to be shed in Galway, Ireland. The affected employees were told that their contracts wouldn't be renewed at staff meetings with management Wednesday morning. Item

> Harvard Medical School researchers have developed a new web-based diagnostic procedure to identify autism more quickly. Report

> Bothell, WA-based Cardiac Science will wind down most of its remaining operations in that area this year. The company had employed roughly 125 people before its January 2011 sale to India's Opto Circuits. Sixty people will be transferred to Wisconsin and California. Story

> InVivo Therapeutics said it expects to be able to launch a human clinical trial for its new biopolymer scaffolding to treat acute spinal cord injuries during the second half of this year. Release

> Revolutions Medical has inked a marketing and distribution deal with Sungwon Medical in South Korea to distribute its RevVac auto-retractable vacuum safety syringe. Release

> Olympus has come to the defense of its nominee for president, Hiroyuki Sasa. Although some have urged votes against the nominee, the company says Sasa has 30 years of experience in its core medical business. Report

> A team has determined how to boost the survival time of fat grafts in breast reconstruction. Those whose breasts were reconstructed using the stromal vascular fraction-enhanced fat grafts maintained 63% of the restored contour and volume a year after surgery. Release

Biotech News

@FierceBiotech: Amazon hungers for genomics data after NIH pact. Story | Follow @FierceBiotech

@JohnCFierce: Another PhRMA fact from Dow Jones: 3,200 trials under way versus 2,400 in 2005. More | Follow @JohnCFierce

@RyanMFierce: An Aussie biotech, ImmunAid, has wrapped a AU$1M round, monitors immune system to gauge optimal delivery time. Release | Follow @RyanMFierce

> Embattled AZ chief: Bigger R&D bets, megadeals not the answer. More

> Biopharma lobby members pumped $49.5B into R&D. Article

> Tioga nabs $10M VC deal amid PhIII for bowel disorder drug. News

Pharma News

@FiercePharma: Lilly chief: We can't cut our way out of this mess. Need new drugs, new sales, too--Bloomberg. Article | Follow @FiercePharma

> Novartis reports patient taking Gilenya developed rare brain disease. Article

> Bloomberg: Bayer to pay $110 million to get out from under 500 Yaz lawsuits. Story

> Merck's Propecia and Proscar linked to sexual dysfunction. More

And Finally... Patients are poor consumers of healthcare and spend double the time purchasing a television as they do looking for a doctor, Quest Diagnostics Chief Medical Officer Jon Cohen said at the TEDMED conference in Washington, D.C. Story

Suggested Articles

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.